Evaluation of utility of pharmacokinetic studies in phase I trials of two oncology drugs

od Wu, Kehua, House, Larry, Ramírez, Jacqueline, Seminerio, Michael J., Ratain, Mark J.
Wydane 2013

Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus

od Seminerio, Michael J., Robson, Matthew J., McCurdy, Christopher R., Matsumoto, Rae R.
Wydane 2012

The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands

od Stavitskaya, Lidiya, Seminerio, Michael J., Matthews-Tsourounis, Marilyn M., Matsumoto, Rae R., Coop, Andrew
Wydane 2010

Sigma (σ) Receptor Ligand, AC927 (N-Phenethylpiperidine Oxalate), Attenuates Methamphetamine-Induced Hyperthermia and Serotonin Damage in Mice

od Seminerio, Michael J., Kaushal, Nidhi, Shaikh, Jamaluddin, Huber, Jason D., Coop, Andrew, Matsumoto, Rae R.
Wydane 2010

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

od Kaushal, Nidhi, Seminerio, Michael J., Robson, Matthew J., McCurdy, Christopher R., Matsumoto, Rae R.
Wydane 2012

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

od Silberstein, Stephen D., Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Ashina, Sait, Katsarava, Zaza
Wydane w J Headache Pain (2020)

In Vitro Evaluation of Guanidine Analogs as Sigma Receptor Ligands for Potential Anti-Stroke Therapeutics

od Behensky, Adam A., Cortes-Salva, Michelle, Seminerio, Michael J., Matsumoto, Rae R., Antilla, Jon C., Cuevas, Javier
Wydane 2013

Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia

od Matsumoto, Rae R., Seminerio, Michael J., Turner, Ryan C., Robson, Matthew J., Nguyen, Linda, Miller, Diane B., O’Callaghan, James P.
Wydane w Pharmacol Ther (2014)

No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study

od Blumenfeld, Andrew M., Stevanovic, Darko M., Ortega, Mario, Cohen, Joshua M., Seminerio, Michael J., Yang, Ronghua, Jiang, Bo, Tepper, Stewart J.
Wydane w Headache (2020)

Synthesis and pharmacological evaluation of indole-based sigma receptor ligands

od Mésangeau, Christophe, Amata, Emanuele, Alsharif, Walid, Seminerio, Michael J., Robson, Matthew J., Matsumoto, Rae R., Poupaert, Jacques H., McCurdy, Christopher R.
Wydane 2011

CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice

od Kaushal, Nidhi, Seminerio, Michael J., Shaikh, Jamaluddin, Medina, Mark A., Mesangeau, Christophe, Wilson, Lisa L., McCurdy, Christopher R., Matsumoto, Rae R.
Wydane 2011

Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study

od Lipton, Richard B., Cohen, Joshua M., Bibeau, Kristen, Galic, Maja, Seminerio, Michael J., Ramirez Campos, Verena, Halker Singh, Rashmi B., Ailani, Jessica
Wydane w Headache (2020)

Immunogenicity of biologic therapies for migraine: a review of current evidence

od Cohen, Joshua M., Ning, Xiaoping, Kessler, Yoel, Rasamoelisolo, Michele, Campos, Verena Ramirez, Seminerio, Michael J., Krasenbaum, Lynda J., Shen, Honglue, Stratton, Jennifer
Wydane w J Headache Pain (2021)

Synthesis and Pharmacological Characterization of a Novel Sigma Receptor Ligand with Improved Metabolic Stability and Antagonistic Effects Against Methamphetamine

od Seminerio, Michael J., Robson, Matthew J., Abdelazeem, Ahmed H., Mesangeau, Christophe, Jamalapuram, Seshulatha, Avery, Bonnie A., McCurdy, Christopher R., Matsumoto, Rae R.
Wydane 2011

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

od Lipton, Richard B., Cohen, Joshua M., Galic, Maja, Seminerio, Michael J., Yeung, Paul P., Aycardi, Ernesto, Bigal, Marcelo E., Bibeau, Kristen, Buse, Dawn C.
Wydane w Headache (2021)